CSU starts FDA approved research on convalescent plasma

Outlet: Collegian

Collegian: Scientists at Colorado State University’s Infectious Disease Research Center are now studying COVID-19 antibodies and their possible effects on patients infected with the disease. The Food and Drug Administration recently authorized convalescent plasma research as a way to treat COVID-19.